Components of physical capacity in patients with chronic obstructive pulmonary disease: Relationship with phenotypic expression

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 105-112

  Márquez Martín, Eduardo ^a   Ramos, Pilar Cejudo ^a   López Campos, José Luis ^a   Gotarredona, María del Pilar Serrano ^a   Herrero, Silvia Navarro ^a   Aguilar, Rodrigo Tallón ^a   Cortes, Emilia Barrot ^a   Ruiz, Francisco Ortega ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Exercise tolerance; Lung function; Phenotypes

Indexed keywords

ADULT; ARTICLE; BLOOD GAS ANALYSIS; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSPNEA; EXERCISE TOLERANCE; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OBSERVATIONAL STUDY; PHYSICAL CAPACITY; PROSPECTIVE STUDY; SPIROMETRY; AGED; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EXERCISE TEST; HOSPITALIZATION; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIOGRAPHY; SKELETAL MUSCLE; SPAIN;

AGED; BLOOD GAS ANALYSIS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHENOTYPE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPAIN; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960069642     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S16646     Document Type: Article

References (50)

1. Global Initiative for Chronic Obstructive Lund Disease (GOLD) 2006. http://www.goldcopd.com/. Accessed July 21, 2007.
2. Hogg JC. Pathophysiology of airfow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709-721.
3. Johnson MA, Woodcock, Rehahn M, Geddes DM. Are "pink puffers" more breathless than "blue bloaters"? Br Med J. 1983;15:286:179-182.
4. Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62:932-937.
5. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology. 2006;11:731-740.
6. Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100:1742-1752.
7. Boschetto P, Quintavalle S, Zeni E, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax. 2006;61:1037-1042.
8. Sin DD, Anthonisen NR, Soriano JB, Agustí AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245-1257.
9. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946.
10. García-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61:772-778.
11. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544-549.
12. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62:115-120.
13. Soler-Cataluña JJ, Sánchez-Sánchez L, Martínez-García MA, et al. Mid-Arm muscle area is a better predictor of mortality tan body mass index in COPD. Chest. 2005;128:2108-2115.
14. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema an sevre airfow obstruction. Am J Respir Crit Care Med. 2006;173:1326-1334.
15. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
16. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airfow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012.
17. Elias Hernandez MT, Fernandez Guerra J, Toral Marin J, Ortega Ruiz F, Sanchez Riera H, Montemayor Rubio T. Reproducibility of a shuttle walking test in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 1997;33:64-68.
18. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580-586.
19. Recomendaciones de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Normativa para la espirometría forzada. Barcelona: Ed. Doyma; 1985.
20. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136:1285-1298.
21. Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959;79:457-467.
22. Recomendaciones SEPAR. Normativa sobre gasometría arterial. Barcelona: Ed. Doyma; 1987.
23. Guell R, Casan P, Sangenis M, et al. The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 1995;31:202-210.
24. Lillegrad WA, Terrio JD. Aprpropriate strength training. Med Clin North Am. 1994;78:457-477.
25. Hamilton A, Killian K, Summers E, et al. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021-2031.
26. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47:1019-1024.
27. ERS Task Force, Palange P, Ward SA, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:185-209.
28. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. 11th edition. Philadelphia: Cea and Febiger, 1980.
29. Whipp BJ, Wagner PD, Agusti A. Determinants of the physiological systems responses to muscular exercise in helathy subjects. Eur Respir Mon. 2007;40:1-35.
30. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377-381.
31. Webb WR. Radiology of obstructive pulmonary disease. AJR Am J Roentgenol. 1997;169:637-647.
32. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379-387.
33. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Am J Respir Crit Care Med. 2000;162:1102-1108.
34. Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest. 1991;100:307-311.
35. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-1440.
36. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-931.
37. Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl. 2003;41:36s-45s.
38. Tashkin DP. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Am J Med. 2006;119:63-72.
39. Kim WD, Ling SH, Coxson HO, et al. The association between small airway obstruction and emphysema phenotypes in COPD. Chest. 2007;131:1372-1378.
40. Izquierdo JL, Almonacid C, Parra T, Perez J. Systemic and lung infam-mation in 2 phenotypes of chronic obstructive pulmonary disease. Arch Bronconeumol. 2006;42:332-337.
41. Fletcher CM, Jone NL, Burrows B, Niden AH. American emphysema and British bronchitis. A standardized comparative study. Am Rev Respir Dis. 1964;90:1-13.
42. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021-2031.
43. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J. 2005;26:703-719.
44. Gosker HR, Zeegers M P, Wouters EF, Schols AM. Muscle fbre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax. 2007;62:944-949.
45. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629-634.
46. Pepin V, Saey D, Laviolette L, Maltais F. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD. 2007;4:195-204.
47. Vassilakopoulos T, Roussos C, Zakynthinos S. The immune response to resistive breathing. Eur Respir J. 2004;24:1033-1043.
48. Albuquerque A, Nery L, Villaca D, et al. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J. 2006;28:939-944.
49. Yende S, Waterer G W, Tolley EA, et al. Infamtory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax. 2006;61:10-16.
50. Toral Marin J, Ortega F, Cejudo P, Elias T, Sanchez H, Montemayor T. Peripheral muscle strength in stable COPD patients: correlation with respiratory function variables and quality of life. Arch Bronconeumol. 1999;35:117-121.